ADVERTISEMENT
Search


PharmacyLibrary

The most current resources for a changing profession. PharmacyLibrary gives you access to APhA’s leading content including 45+ digital books, PharmacotherapyFirst and the Cultural Toolkit all at your fingertips.

Learn more today  

APhA’s Learning Library

We’re excited to announce the launch of the new APhA Learning Library! This new platform will make it easier than ever for you to get the education you need. Read about some key highlights of our new system.

Learn more  

Share your Workplace Experiences

The Pharmacy Workplace and Well-being Reporting (PWWR) tool offers a secure and confidential platform for the entire pharmacy community to anonymously share both positive and negative workplace experiences.

Submit to PWWR  

Advertisement

Featured Education

Upcoming Events

Practice Resources

Tools and resources to support your practice

Access Now  

image-6
 

Latest from APhA

View CEO Blog

Recent pharmacy closures and ECAPS legislation

Like so many of you, we’ve been continuing to follow reports in the media about pharmacy closures. It seems like each of those stories focuses on the obvious downside to the closures—a local place to get prescriptions filled is going away. While the inconvenience of having to get prescriptions filled miles away can be substantial

RSS

Statement on pharmacy closures and ECAPS legislation

Washington, DC—APhA is deeply concerned about the ongoing reports of pharmacy closures, which primarily highlight the inconvenience of losing a local prescription source. However, this issue extends far beyond inconvenience; it jeopardizes access to trusted pharmacists, particularly in rural and underserved communities

RSS

Pharmacy news

View all news

Whooping cough cases are on the rise, says CDC

CDC reports that cases of whooping cough in the United States have reached the highest level in 10 years, with West Coast and Middle Atlantic regions standing out as current hot spots.

ACIP: Extra COVID vaccine for older adults and PCV for 50 and older

CDC’s Advisory Committee on Immunization Practices (ACIP) has voted to recommend a second dose of the 2024–25 COVID-19 vaccine for those aged 65 years and older who have moderate or severe immunocompromising conditions.

RSS

ADVERTISEMENT